Headquarters
2500 WESTCHESTER AVENUE, PURCHASE, NY 10577-2540, US
PURCHASE, NY, US
COGNITION THERAPEUTICS, INC.
From the company
Cognition Therapeutics, Inc. is a clinical-stage neuroscience company developing oral medications designed to treat neurodegenerative disorders. Its lead candidate, zervimesine (CT1812), is an investigational first-in-class small-molecule oral therapy designed to protect brain synapses by blocking toxic protein oligomers, and is being investigated for dementia with Lewy bodies (DLB) and Alzheimer's disease.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.